Literature DB >> 22585941

Gender differences in chemical carcinogenesis in National Toxicology Program 2-year bioassays.

Sandeep Kadekar1, Shyamal Peddada, Ilona Silins, John E French, Johan Högberg, Ulla Stenius.   

Abstract

Differences in cancer incidences between men and women are often explained by either differences in environmental exposures or by influences of sex hormones. However, there are few studies on intrinsic gender differences in susceptibility to chemical carcinogens. We have analyzed the National Toxicology Program (NTP) database for sex differences in rat responses to chemical carcinogens. We found that the odds that male rat bioassays were assigned a higher level of evidence than female rat bioassays was 1.69 (p < .001). Of 278 carcinogenic chemicals in the database, 201 (72%) exhibited statistical gender differences (p ≤ .05) in at least one nonreproductive organ. One hundred thirty of these 201 chemicals induced gender-specific tumors in male rats and 59 in female rats. Sixty-eight chemicals induced tumors in males but no tumors in females. Less than one third (i.e., 19 chemicals) induced tumors in females but not males. Male-specific tumors included pancreatic and skin tumors, and female-specific tumors included lung tumors. For some tumor sites, these differences in gender susceptibility can be associated with literature data on sex hormone receptor expression. In conclusion, gender-specific tumors were common. The male dominance is in line with recent human data, and the male susceptibility to carcinogens should be further studied.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22585941      PMCID: PMC4778959          DOI: 10.1177/0192623312446527

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  55 in total

1.  Serum estrogen and tumor-positive estrogen receptor-alpha are strong prognostic classifiers of non-small-cell lung cancer survival in both men and women.

Authors:  Susan E Olivo-Marston; Leah E Mechanic; Steen Mollerup; Elise D Bowman; Alan T Remaley; Michele R Forman; Vidar Skaug; Yun-Ling Zheng; Aage Haugen; Curtis C Harris
Journal:  Carcinogenesis       Date:  2010-08-20       Impact factor: 4.944

Review 2.  Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics.

Authors:  Gail D Anderson
Journal:  J Womens Health (Larchmt)       Date:  2005 Jan-Feb       Impact factor: 2.681

3.  Effects of sex steroid hormones on pancreatic cancer in the rat.

Authors:  D S Longnecker; C Sumi
Journal:  Int J Pancreatol       Date:  1990 Aug-Nov

Review 4.  Cancer in rodents: does it tell us about cancer in humans?

Authors:  Vladimir N Anisimov; Svetlana V Ukraintseva; Anatoly I Yashin
Journal:  Nat Rev Cancer       Date:  2005-10       Impact factor: 60.716

Review 5.  Framework for gender differences in human and animal toxicology.

Authors:  Michael Gochfeld
Journal:  Environ Res       Date:  2006-04-17       Impact factor: 6.498

6.  Steroid hormone receptor expression in renal cell carcinoma: an immunohistochemical analysis of 182 tumors.

Authors:  Cord Langner; Manfred Ratschek; Peter Rehak; Luigi Schips; Richard Zigeuner
Journal:  J Urol       Date:  2004-02       Impact factor: 7.450

7.  Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma.

Authors:  Wen-Lung Ma; Cheng-Lung Ma; Cheng-Lung Hsu; Ming-Heng Wu; Chun-Te Wu; Cheng-Chia Wu; Jiann-Jyh Lai; Yuh-Shan Jou; Chun-Wei Chen; Shuyuan Yeh; Chawnshang Chang
Journal:  Gastroenterology       Date:  2008-05-22       Impact factor: 22.682

8.  Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.

Authors:  Willscott E Naugler; Toshiharu Sakurai; Sunhwa Kim; Shin Maeda; Kyounghyun Kim; Ahmed M Elsharkawy; Michael Karin
Journal:  Science       Date:  2007-07-06       Impact factor: 47.728

9.  Sex differences in risk of lung cancer: Expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts.

Authors:  Steen Mollerup; Gisle Berge; Rita Baera; Vidar Skaug; Alan Hewer; David H Phillips; Lodve Stangeland; Aage Haugen
Journal:  Int J Cancer       Date:  2006-08-15       Impact factor: 7.396

10.  The limits of two-year bioassay exposure regimens for identifying chemical carcinogens.

Authors:  James Huff; Michael F Jacobson; Devra Lee Davis
Journal:  Environ Health Perspect       Date:  2008-06-30       Impact factor: 9.031

View more
  10 in total

1.  Androgen receptor actions modify skin structure and chemical carcinogen-induced skin cancer susceptibility in mice.

Authors:  Ulla Simanainen; Tegan Ryan; Desmond Li; Francia Garces Suarez; Yan Ru Gao; Geoff Watson; Yiwei Wang; David J Handelsman
Journal:  Horm Cancer       Date:  2015-01-07       Impact factor: 3.869

2.  Gender differences in cancer susceptibility: role of oxidative stress.

Authors:  Imran Ali; Johan Högberg; Jui-Hua Hsieh; Scott Auerbach; Anna Korhonen; Ulla Stenius; Ilona Silins
Journal:  Carcinogenesis       Date:  2016-07-31       Impact factor: 4.944

Review 3.  Sex Differences in Human and Animal Toxicology.

Authors:  Michael Gochfeld
Journal:  Toxicol Pathol       Date:  2016-11-28       Impact factor: 1.902

Review 4.  The spectrum of sex differences in cancer.

Authors:  Joshua B Rubin
Journal:  Trends Cancer       Date:  2022-02-18

5.  Exocrine pancreatic carcinogenesis and autotaxin expression.

Authors:  Sandeep Kadekar; Ilona Silins; Anna Korhonen; Kristian Dreij; Lauy Al-Anati; Johan Högberg; Ulla Stenius
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

Review 6.  Sexual Differentiation Specifies Cellular Responses to DNA Damage.

Authors:  Lauren Broestl; Joshua B Rubin
Journal:  Endocrinology       Date:  2021-11-01       Impact factor: 5.051

7.  Data mining in the U.S. National Toxicology Program (NTP) database reveals a potential bias regarding liver tumors in rodents irrespective of the test agent.

Authors:  Matthias Ring; Bjoern M Eskofier
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

8.  Activation of Nrf2 in the liver is associated with stress resistance mediated by suppression of the growth hormone-regulated STAT5b transcription factor.

Authors:  John Rooney; Keiyu Oshida; Naresh Vasani; Beena Vallanat; Natalia Ryan; Brian N Chorley; Xuting Wang; Douglas A Bell; Kai C Wu; Lauren M Aleksunes; Curtis D Klaassen; Thomas W Kensler; J Christopher Corton
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

Review 9.  Sex-biased adaptive immune regulation in cancer development and therapy.

Authors:  Johanna M Schafer; Tong Xiao; Hyunwoo Kwon; Katharine Collier; Yuzhou Chang; Hany Abdel-Hafiz; Chelsea Bolyard; Dongjun Chung; Yuanquan Yang; Debasish Sundi; Qin Ma; Dan Theodorescu; Xue Li; Zihai Li
Journal:  iScience       Date:  2022-07-04

10.  Recurrent amplification of RTEL1 and ABCA13 and its synergistic effect associated with clinicopathological data of gastric adenocarcinoma.

Authors:  T M Araújo; A D Seabra; E M Lima; P P Assumpção; R C Montenegro; S Demachki; R M Burbano; A S Khayat
Journal:  Mol Cytogenet       Date:  2016-06-29       Impact factor: 2.009

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.